IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”
IPO’s Comments to China’s NMPA on the "Implementation Measures for [...]
A Fresh NEW Look for the Awards Celebration on December 7th
A FRESH NEW LOOK FOR THE AWARDS CELEBRATION ON DECEMBER [...]
DOJ, USPTO, AND NIST WITHDRAW 2019 POLICY STATEMENT ON SEPS SUBJECT TO F/RAND COMMITMENTS
DOJ, USPTO, and NIST Withdraw 2019 Policy Statement on SEPs [...]
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT CORRECTION OF “OBVIOUS CLERICAL ERROR” IN CLAIM
**Federal Circuit Upholds District Court Correction of “Obvious Clerical Error” [...]
IPO Annual Meeting Program Features Session on Global Rate-Setting for Standards-Essential Patents
IPO ANNUAL MEETING PROGRAM FEATURES SESSION ON GLOBAL RATE-SETTING FOR [...]
IPO Comments on Countries with Inadequate IP Protections
IPO COMMENTS ON COUNTRIES WITH INADEQUATE IP PROTECTION Yesterday IPO [...]
Exclusive Q&A with Sen. Thom Tillis
DAILY NEWS SPECIAL FEATURE: Q&A WITH SENATOR THOM TILLIS Senator [...]
Slay In Your Lane Authors Sue BBC for Trademark Infringement
IP IN THE MASS MEDIA Slay In Your Lane Authors [...]
Japan Passes Partial Revision of Patent Act and Design Act
JAPAN PASSES PARTIAL REVISION OF PATENT ACT AND DESIGN ACT [...]
Section 101: Revised USPTO Guidance on Patent Eligbility
This webinar features the USPTO’s Deputy Commissioner for Patent Examination [...]